Researchers Use Nanoparticles to Test Treatment for Liver Disease

June 25, 2018 | Katie Neith

In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.

Continue Reading

Einstein on Cancer: New Paper Explores Relativity and Aging

July 3, 2018 | Abe Rosenberg

As director of City of Hope's Division of Mathematical Oncology, Russell Rockne, Ph.D., spends his days building mathematical models to help us better understand how cancer works.

City of Hope Awarded $3.7 million to Develop Glioblastoma Clinical Trial

June 29, 2018 | Letisia Marquez

California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.

Researcher's Ovarian Cancer Discovery Takes on Special Meaning

June 27, 2018 | City of Hope

The results of a study published earlier this year by TGen researchers (City of Hope affiliate) in the journal Clinical Cancer Research suggest an existing leukemia drug, ponatinib, shows promise against SCCOHT.

Researchers Use Nanoparticles to Test Treatment for Liver Disease

June 25, 2018 | Katie Neith

In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.

Bringing Leading-edge Care to the Community: Hans Schoellhammer, M.D.

June 13, 2018 | Travis Marshall

Surgical oncologist Hans Schoellhammer, M.D., has always been fascinated by the immunotherapies that help a patient’s own immune system attack cancer, and at City of Hope, he focuses his talents on treating melanoma.

City of Hope Guides ASCO’s New Geriatric Cancer Recommendations

June 8, 2018 | Saundra Young

City of Hope physicians Arti Hurria, M.D., a geriatric oncologist, and William Dale, M.D., Ph.D., a geriatrician and palliative care physician, co-chaired the panel that developed the new ASCO guidelines designed to help doctors assess and manage care for older adults.

City of Hope Researchers Publish First Report on a Protein Inhibitor for Advanced Bladder Cancer

June 8, 2018 | Letisia Marquez

Advanced bladder cancer is particularly difficult to treat. The five-year survival rate for Stage 4 bladder cancer is only about 15 percent. Now, City of Hope researchers have discovered a that a novel drug blocks a key protein that drives the disease.

Benjamin Djulbegovic, M.D., Ph.D., joins the Department of Supportive Care Medicine

June 8, 2018 | City of Hope

Benjamin Djulbegovic, M.D., Ph.D. is a professor and director of research in the Department of Supportive Care Medicine.

Looking Ahead: A Conversation with Steven T. Rosen, M.D., Provost and Chief Scientific Officer

May 30, 2018 | Michael Easterling

Steven T. Rosen, M.D., just marked his fourth year at City of Hope as provost and chief scientific officer. On the occasion of his first four years at City of Hope and the recent five-year renewal of a National Cancer Institute grant, we sat down with Rosen to reflect on his time at City of Hope.

Stephen Forman, M.D., Inducted into AAP

May 30, 2018 | Michael Easterling

Stephen J. Forman, M.D., the Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, has been inducted as a member of the Association of American Physicians.